ATE352641T1 - Zirkulierendes epstein-barr virus dna im serum der patienten mit gastrischem krebs - Google Patents

Zirkulierendes epstein-barr virus dna im serum der patienten mit gastrischem krebs

Info

Publication number
ATE352641T1
ATE352641T1 AT02710132T AT02710132T ATE352641T1 AT E352641 T1 ATE352641 T1 AT E352641T1 AT 02710132 T AT02710132 T AT 02710132T AT 02710132 T AT02710132 T AT 02710132T AT E352641 T1 ATE352641 T1 AT E352641T1
Authority
AT
Austria
Prior art keywords
serum
gastric cancer
epstein
circulation
cancer patients
Prior art date
Application number
AT02710132T
Other languages
English (en)
Inventor
Yuk Ming Dennis Lo
Wing Yee Chan
Kwok Wai Ng
Original Assignee
Univ Hong Kong Chinese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hong Kong Chinese filed Critical Univ Hong Kong Chinese
Application granted granted Critical
Publication of ATE352641T1 publication Critical patent/ATE352641T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/705Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT02710132T 2001-01-31 2002-01-30 Zirkulierendes epstein-barr virus dna im serum der patienten mit gastrischem krebs ATE352641T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26556801P 2001-01-31 2001-01-31

Publications (1)

Publication Number Publication Date
ATE352641T1 true ATE352641T1 (de) 2007-02-15

Family

ID=23010993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02710132T ATE352641T1 (de) 2001-01-31 2002-01-30 Zirkulierendes epstein-barr virus dna im serum der patienten mit gastrischem krebs

Country Status (7)

Country Link
US (2) US6753137B2 (de)
EP (1) EP1356124B1 (de)
JP (1) JP2004536282A (de)
CN (1) CN1272448C (de)
AT (1) ATE352641T1 (de)
DE (1) DE60217823D1 (de)
WO (1) WO2002061148A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030228575A1 (en) * 2001-01-31 2003-12-11 Yuk Ming Dennis Lo Combination of circulating epstein-barr virus (EBV) DNA in the serum or plasma of patients and a method to assess EBV subtypes for the prediction and detection of epstein-barr virus associated cancers
ATE346170T1 (de) * 2003-10-29 2006-12-15 Maurice Stroun Verfahren zur diagnose von krebs
JP4182227B2 (ja) * 2005-09-09 2008-11-19 国立大学法人 岡山大学 ウイルス潜伏感染の検査方法および検査用キット
CN101153336B (zh) * 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
US7842482B2 (en) * 2007-02-26 2010-11-30 The Chinese University Of Hong Kong Methods and kits for diagnosis, prognosis or monitoring of Epstein-Barr virus (EBV)-associated cancer
KR20180090396A (ko) 2008-01-18 2018-08-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
CA2779750C (en) 2009-11-06 2019-03-19 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive diagnosis of graft rejection in organ transplant patients
MX382244B (es) 2010-07-23 2025-03-13 Harvard College Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
AU2011280944A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting diseases or conditions using phagocytic cells
AU2011280936A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
CA3069089A1 (en) * 2011-09-22 2013-03-28 Lineage Biosciences, Inc. Compositions and methods for analyzing heterogeneous samples
EP2965086A4 (de) 2013-03-09 2017-02-08 Harry Stylli Verfahren zum nachweis von prostatakrebs
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014144822A2 (en) 2013-03-15 2014-09-18 Immumetrix, Inc. Methods and compositions for tagging and analyzing samples
CN105829589B (zh) 2013-11-07 2021-02-02 小利兰·斯坦福大学理事会 用于分析人体微生物组及其组分的无细胞核酸
CN103642945B (zh) * 2013-12-30 2019-01-08 上海星耀医学科技发展有限公司 一种含内参照的高灵敏Epstein-Barr病毒荧光定量PCR试剂盒
WO2016040843A1 (en) 2014-09-11 2016-03-17 Harry Stylli Methods of detecting prostate cancer
CN104604799B (zh) * 2015-02-05 2017-11-21 南华大学 一种鉴定eb病毒对淋巴瘤的诱发性的方法
AU2016264102A1 (en) 2015-05-18 2017-12-21 Karius, Inc. Compositions and methods for enriching populations of nucleic acids
EP3433382B1 (de) 2016-03-25 2021-09-01 Karius, Inc. Synthetische nukleinsäure-spike-ins
WO2018191563A1 (en) 2017-04-12 2018-10-18 Karius, Inc. Sample preparation methods, systems and compositions
RU2659134C1 (ru) * 2017-09-20 2018-06-28 Федеральное государственное бюджетное образовательное учреждение высшего образования "Смоленский государственный медицинский университет" министерства здравоохранения Российской Федерации Способ оценки степени тяжести течения хронического эрозивного гастрита, ассоциированного с helicobacter pylori и вирусом эпшейн-барр
JP7239973B2 (ja) * 2017-12-19 2023-03-15 国立大学法人山口大学 前癌病変又は癌の有無の予測を補助する方法
CA3082601A1 (en) 2018-03-16 2019-09-19 Karius, Inc. Sample series to differentiate target nucleic acids from contaminant nucleic acids
WO2019232436A1 (en) * 2018-06-01 2019-12-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Gamma herpesvirus circular rna
EP3830302B1 (de) * 2018-08-01 2022-10-05 Gen-Probe Incorporated Zusammensetzungen und verfahren zum nachweis von nukleinsäuren des epstein-barr-virus
CN109022619A (zh) * 2018-08-27 2018-12-18 郑州安图生物工程股份有限公司 一种用于检测人类疱疹病毒4型的试剂盒
DK4428234T3 (da) 2018-11-21 2026-01-26 Karius Inc Direkte-til-bibliotek-fremgangsmåder, systemer og sammensætninger
JP7649285B2 (ja) * 2019-07-25 2025-03-19 エフ. ホフマン-ラ ロシュ アーゲー エプスタイン・バーウイルス(ebv)を検出するための組成物および方法
US20220373548A1 (en) * 2019-10-24 2022-11-24 Arizona Board Of Regents On Behalf Of Arizona State University Novel antibodies for detecting epstein barr virus-positive gastric cancer
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
WO2025216320A1 (ja) * 2024-04-12 2025-10-16 国立大学法人熊本大学 牛伝染性リンパ腫の病勢の検査方法、プライマー、cfDNA定量キット、及び牛伝染性リンパ腫の病勢の検査キット

Also Published As

Publication number Publication date
CN1489634A (zh) 2004-04-14
US6753137B2 (en) 2004-06-22
EP1356124A2 (de) 2003-10-29
WO2002061148A2 (en) 2002-08-08
JP2004536282A (ja) 2004-12-02
CN1272448C (zh) 2006-08-30
US20020192642A1 (en) 2002-12-19
DE60217823D1 (de) 2007-03-15
HK1061048A1 (en) 2004-09-03
US20040005551A1 (en) 2004-01-08
WO2002061148A3 (en) 2003-05-15
EP1356124B1 (de) 2007-01-24

Similar Documents

Publication Publication Date Title
ATE352641T1 (de) Zirkulierendes epstein-barr virus dna im serum der patienten mit gastrischem krebs
WO2002057787A3 (en) Detection of survivin in the biological fluids of cancer patients
ATE386938T1 (de) Ykl-40 als marker und indikator zur prognose von krebs und detektion von infektionen
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
CA2384579A1 (en) Early cancer tumor marker
AU1038402A (en) Assay for directly detecting a rs virus related biological cell in a body fluid sample
CY1115366T1 (el) Δεικτες ογκου
ATE337413T1 (de) Methoden zur verbesserung der sensitivität und spezifität von screeningverfahren für krebs und krebs-vorstufen
WO2002054067A3 (en) Detection of analytes
DE50113548D1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
WO2004067570A3 (en) Prostate cancer diagnosis and treatment
BR0314155A (pt) Métodos para diagnosticar câncer cervical
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
DE60110407D1 (de) Reagenz zur bestimmung von blutplättchen-mikroteilchen
DE69929785D1 (de) Verfahren zur Diagnose, Erkennung, und Einstufung von Dickdarmkrebs
WO2000026668A3 (en) S100 proteins and autoantibodies as serum markers for cancer
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
CA3116522A1 (en) A method of detecting small rna
CA2531451A1 (en) Methods and nucleic acids for analyses of colorectal cell proliferative disorders
WO1998014611A3 (en) Detection and identification of non-polio enteroviruses
WO2006034879A3 (en) Epigenetic methods and nucleic acids for the detection of lung cell proliferative disorders
EP1505161A3 (de) Nachweis von Polymorphismen in Epstein-Barr-Virus (EBV) DNA zur Vorhersage und zum Nachweis von EBV-assoziierten Tumoren
WO2005001140A3 (en) Methods and nucleic acids for the analysis of colon cell proliferative disorders
WO2004029216A3 (en) Diagnosis of invasive mold infection
WO2001032916A3 (en) Automated lysophospholipid assay and methods of detecting cancer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties